Cargando…

Tozinameran: Cerebral venous sinus thrombosis and immune thrombotic thrombocytopenia: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023655/ http://dx.doi.org/10.1007/s40278-022-13911-y

Ejemplares similares

Tozinameran: Cerebral venous sinus thrombosis: case report
Publicado: (2022)

Tozinameran: Cerebral Venous Sinus Thrombosis: case report
Publicado: (2022)

AZD-1222: Cerebral venous sinus thrombosis with thrombotic thrombocytopenia: case report
Publicado: (2022)

AZD-1222: Immune thrombotic thrombocytopenia and cerebral sinus venous thrombosis: 2 case reports
Publicado: (2022)

Multiple drugs: Immune thrombotic thrombocytopenia as cerebral sinus venous thrombosis, and lack of efficacy: case report
Publicado: (2022)

Elasomeran/tozinameran: Cerebral venous sinus thrombosis: 3 case reports
Publicado: (2022)

Ad26.COV2-S: Thrombotic thrombocytopenia and cerebral venous sinus thrombosis: case report
Publicado: (2021)

AZD-1222: Thrombotic thrombocytopenia causing cerebral venous sinus thrombosis and hepatic veins thrombosis: case report
Publicado: (2022)

Tozinameran: Vaccine-induced immune thrombotic thrombocytopenia: case report
Publicado: (2022)

Tozinameran: Cerebral venous thrombosis : 2 case reports
Publicado: (2021)

Tozinameran: Cerebral venous thrombosis: 3 case reports
Publicado: (2021)

Ad26.cov2-s/AZD-1222: Cerebral venous sinus thrombosis and thrombotic thrombocytopenia: 3 case reports
Publicado: (2022)

Massive cerebral venous thrombosis due to vaccine-induced immune thrombotic thrombocytopenia
por: Bonato, Sara, et al.
Publicado: (2021)

AZD-1222: Cerebral venous sinus thrombosis and thrombosis with thrombocytopenia syndrome: case report
Publicado: (2021)

Azd-1222: Cerebral venous thrombosis and vaccine-induced immune thrombotic thrombocytopenia: 3 case reports
Publicado: (2022)

Elasomeran/tozinameran: Cerebral venous thrombosis: 9 case reports
Publicado: (2022)

AZD-1222: Vaccine-induced immune thrombotic thrombocytopenia, cerebral venous thrombosis and deep vein thrombosis: 3 case reports
Publicado: (2022)

ChAdOx1 nCOV-19 vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis (CVST)
por: Suresh, Preethi, et al.
Publicado: (2021)

Cerebral arterial and venous thrombosis due to COVID-19 vaccine-induced immune thrombotic thrombocytopenia
por: Pang, Elaine, et al.
Publicado: (2022)

Long-term outcome of patients with vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis
por: Kehr, Sarah, et al.
Publicado: (2022)

Cerebral venous sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopenia in middle-income countries
por: van de Munckhof, Anita, et al.
Publicado: (2023)

Ad26.COV2-S: Cerebral Venous Sinus Thrombosis with Thrombocytopenia: 14 case reports
Publicado: (2021)

Multiple drugs: Cerebral venous sinus thrombosis, thrombocytopenia and lack of efficacy: 2 case reports
Publicado: (2021)

Cerebral venous sinus thrombosis associated with SRA-negative heparin-induced thrombocytopenia: case report
por: Silva, Floyd D., et al.
Publicado: (2023)

Vaccine-induced immune thrombotic thrombocytopenia (VITT) with cerebral venous sinus thrombosis (CVST): a case report from Malaysia
por: Liam, Christopher Chin Keong, et al.
Publicado: (2022)

Cerebral venous sinus thrombosis in immune thrombocytopenia patients treated with thrombopoietin receptor agonist: Case reports and literature review
por: Teekaput, Chutithep, et al.
Publicado: (2022)

Late-Onset Vaccine-Induced Immune Thombotic Thrombocytopenia (VITT) with Cerebral Venous Sinus Thrombosis
por: Saleh, Maruan, et al.
Publicado: (2022)

Tozinameran: Secondary immune thrombocytopenia: case report
Publicado: (2022)

Tozinameran: Exacerbation of immune thrombocytopenia : case report
Publicado: (2021)

AZD-1222/fondaparinux-sodium/immune-globulin: Vaccine-induced immune thrombotic thrombocytopenia leading to cerebral arterial and venous thrombosis: case report
Publicado: (2022)

Tozinameran: Immune thrombotic thrombocytopenic purpura: case report
Publicado: (2022)

Azd-1222: Thrombotic thrombocytopaenia and central venous sinus thrombosis: case report
Publicado: (2021)

Early Outcomes of Bivalirudin Therapy for Thrombotic Thrombocytopenia and Cerebral Venous Sinus Thrombosis After Ad26.COV2.S Vaccination
por: Clark, Richard Todd, et al.
Publicado: (2021)

A Rare Case of Extensive Cerebral Venous Sinus Thrombosis Complicated by Heparin-Induced Thrombocytopenia
por: Jang Khan, Noman Ahmed, et al.
Publicado: (2022)

COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) and Cerebral Venous Sinus Thrombosis (CVST)- Lessons for India
por: Khan, Erum, et al.
Publicado: (2022)

Time to consider neuroinflammation as a booster effect of cerebral venous sinus thrombosis in vaccine-induced immune thrombotic thrombocytopenia?
por: Marchandot, Benjamin, et al.
Publicado: (2021)

Tozinameran: Immune thrombocytopenia purpura flare: case report
Publicado: (2022)

Tozinameran: Fever, headache and immune thrombocytopenia: case report
Publicado: (2022)

Azd-1222: Thrombocytopenia and intracranial venous sinus thrombosis: 3 case reports
Publicado: (2021)

Epidemiology of cerebral venous sinus thrombosis and cerebral venous sinus thrombosis with thrombocytopenia in the United States, 2018 and 2019
por: Payne, Amanda B., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0tf9tj6kqi8bn65lifcoumftmm